Literature DB >> 17296173

Oxidative status and serum PON1 activity in beta-thalassemia minor.

Sahbettin Selek1, Mehmet Aslan, Mehmet Horoz, Mustafa Gur, Ozcan Erel.   

Abstract

OBJECTIVES: Paraoxonase-1 (PON1) deficiency is related to increased susceptibility to low density lipoprotein oxidation and development of atherosclerosis. The aim of this study was to investigate paraoxonase and arylesterase activities along with oxidative status parameters, and to find out if there is any increased susceptibility to atherogenesis, which might be reflected with increased oxidative stress and decreased serum PON1 activity in beta-thalassemia minor (BTM) subjects. DESIGN AND METHODS: Thirty-two subjects with BTM and 28 healthy subjects as control were enrolled in the study. Serum paraoxonase and arylesterase activities, lipid hydroperoxide (LOOH) levels, total antioxidant capacity (TAC), total oxidant status (TOS) and oxidative stress index (OSI) were determined.
RESULTS: Serum TAC, paraoxonase and arylesterase activities were significantly lower in BTM subjects than controls (for all p<0.001), while TOS, LOOH levels and OSI were significantly higher (p<0.001, p<0.05 and p<0.001; respectively). In BTM subjects, OSI, TOS, LOOH levels and TAC were significantly correlated with serum paraoxonase (r=-0.245, p<0.05; r=-0.231, p<0.05; r=-0.264, p<0.05 and, r=0.342, p<0.05, respectively) and arylesterase activities (r=-0.332, p<0.05, r=-0.308, p<0.05; r=-0.320, p<0.05 and r=0.443, p<0.05). Additionally, hemoglobin level was also correlated with serum paraoxonase (r=0.501, p<0.001) and arylesterase activities (r=0.501, p<0.001), TAC (r=0.402, p<0.05), TOS (r=-0.274, p<0.05) and OSI (r=-0.352, p<0.05).
CONCLUSIONS: Oxidative stress is increased, while serum PON1 activity is decreased in BTM subjects. Decrease in PON1 activity seems to be associated with both the degree of oxidative stress and anemia. BTM subjects may be more prone to development of atherogenesis due to low serum PON1 activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296173     DOI: 10.1016/j.clinbiochem.2006.10.028

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia.

Authors:  Supeenun Unchern; Narumon Laohareungpanya; Yupin Sanvarinda; Kovit Pattanapanyasat; Pansakorn Tanratana; Udom Chantharaksri; Nathawut Sibmooh
Journal:  Lipids       Date:  2010-06-09       Impact factor: 1.880

2.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

3.  Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects.

Authors:  Alkmini T Anastasiadi; Vassilis L Tzounakas; Monika Dzieciatkowska; Vasiliki-Zoi Arvaniti; Effie G Papageorgiou; Issidora S Papassideri; Konstantinos Stamoulis; Angelo D'Alessandro; Anastasios G Kriebardis; Marianna H Antonelou
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

4.  Respiratory Burst Enzymes, Pro-Oxidants and Antioxidants Status in Bangladeshi Population with β-Thalassemia Major.

Authors:  Md Faruk Hossain; Md Ismail; Arifur Rahman Tanu; Hossain Uddin Shekhar
Journal:  N Am J Med Sci       Date:  2015-06

5.  Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia.

Authors:  Musa Cura; Ahmet Koç; Nurten Aksoy; Zeynep Canan Özdemir
Journal:  Blood Res       Date:  2016-12-23

6.  Foxo3 gene expression and oxidative status in beta-thalassemia minor subjects.

Authors:  Sandra Stella Lazarte; María Eugenia Mónaco; Magdalena María Terán; Ana Cecilia Haro; Miryam Emilse Ledesma Achem; Blanca Alicia Issé
Journal:  Rev Bras Hematol Hemoter       Date:  2017-02-22

7.  Erythrocyte Catalase Activity in More Frequent Microcytic Hypochromic Anemia: Beta-Thalassemia Trait and Iron Deficiency Anemia.

Authors:  Sandra Stella Lazarte; María Eugenia Mónaco; Cecilia Laura Jimenez; Miryam Emilse Ledesma Achem; Magdalena María Terán; Blanca Alicia Issé
Journal:  Adv Hematol       Date:  2015-10-07

8.  Could Heterozygous Beta Thalassemia Provide Protection Against Multiple Sclerosis?

Authors:  Mehmet Ali Cikrikcioglu; Muhammed Emin Ozcan; Gulistan Halac; Ilhami Gultepe; Kenan Celik; Yahya Sekin; Elif Ece Eser; Sebnem Burhan; Guven Cetin; Omer Uysal
Journal:  Med Sci Monit       Date:  2016-12-11

Review 9.  Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview.

Authors:  Débora Levy; Cadiele Oliana Reichert; Sérgio Paulo Bydlowski
Journal:  Antioxidants (Basel)       Date:  2019-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.